Ultragenyx Pharma (RARE), Kyowa Kirin Report Submission of Supplemental Biologics License Application to FDA for Crysvita (burosumab)
Go back to Ultragenyx Pharma (RARE), Kyowa Kirin Report Submission of Supplemental Biologics License Application to FDA for Crysvita (burosumab)| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 28.76 -0.27 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.03 | 52 Week High | $117.12 | |||
| Open | $28.58 | 52 Week Low | $46.52 | |||
| Day High | $29.39 | P/E | N/A | |||
| Day Low | $28.50 | EPS | $-1.97 | |||
| Volume | 2,043,024 | |||||
